Parry, Aled J. http://orcid.org/0000-0001-5192-3727
Reik, Wolf http://orcid.org/0000-0003-0216-9881
Funding for this research was provided by:
Wellcome Trust (215912/Z/19/Z)
Article History
First Online: 9 May 2022
Competing interests
: W.R. is a consultant and shareholder of Cambridge Epigenetix. W.R. is employed by Altos Labs. The remaining authors declare no competing interests.